Med-Fine Capital
Venture capitalShanghai · Seed–Late Stage · 8 people tracked
Find your way into Med-Fine Capital
32 people in our graph share verified history with the Med-Fine Capital team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Early-stage healthcare and biotech investors backing China-based companies developing bispecific antibodies, ADCs, and T-cell engagers, offering tailored global expansion strategies and regional network ties including Southeast Asia.
Team · 8 people
from curated & public directoriesFrequently asked questions
- What stage does Med-Fine Capital invest at?
- Med-Fine Capital invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What sectors does Med-Fine Capital focus on?
- Med-Fine Capital focuses on Biotech, Healthtech, Medical Devices.
- Where is Med-Fine Capital located?
- Med-Fine Capital is headquartered in Shanghai, CN.
- Does Med-Fine Capital lead rounds?
- Med-Fine Capital typically participates in rounds rather than leading them.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.



.jpeg)